Overall, these findings demonstrate that delphinidin, an epigenetic demethylating agent of the Nrf2 promoter, may activate the Nrf2-ARE pathway, suggesting that it might be used as a skin cancer chemopreventive agent. Here, NFE2L2 is linked to skin cancer.